WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $13.78, but opened at $13.1940. WuXi Biologics (Cayman) shares last traded at $13.20, with a volume of 399 shares changing hands.
Analyst Ratings Changes
Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.
View Our Latest Analysis on WXXWY
WuXi Biologics (Cayman) Price Performance
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Further Reading
- Five stocks we like better than WuXi Biologics (Cayman)
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
- Can Apple Overtake NVIDIA as the World’s Most Valuable Company?
- Meta Platforms’ Petal Cable Puts Corning at the Center of AI’s Bandwidth Boom
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
